Vertex
The Executive Director, Global Commercial Strategy (GCS) Immunology - TCE serves as the senior commercial leader for T-cell engager programs within the Immunology vertical. This role owns the commercial strategy for the TCE portfolio across various indications, including gMG, lupus, systemic sclerosis, and myositis. The position involves co-leading the Immunology TCE Program Team, shaping development plans, and leading global launch preparation for advancing TCE indications.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1989
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vertex.
Bamco Inc. NY Trims Stake in Vertex Pharmaceuticals
1 day ago
Global Commercial Director, T-cell Engager Therapies, NHL
AstraZeneca
Senior Director, Clinical Operations (autoimmune)
Janux Therapeutics
US Medical Director – Immunology
AstraZeneca
Global Head of Marketing, Immunology LCM
American Association of Physicists in Medicine
Director, US Commercial, Cell Therapy Autoimmune
Bristol Myers Squibb
Global Commercial Director, Immunology Cell Therapy
AstraZeneca